Gilead Sciences market cap GILD

Share price times shares outstanding: what the whole company sells for, since 2009.

Gilead Sciences is worth $193.5B at the close on Oct 23, 2026, at $156.04 a share.

That is up 29% over the last year and up 138% over five years.

Its highest close in our data was $193.7B in Oct 2026.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$193.5B	$150.2B	$193.7B	+25%
2025	$154.7B	$112B	$157.1B	+32%
2024	$117.3B	$80.1B	$120.2B	+16%
2023	$100.9B	$92.8B	$110.5B	−6%
2022	$107.7B	$72.7B	$111.7B	+18%
2021	$91.1B	$77.2B	$91.1B	+25%
2020	$73B	$71.5B	$106.1B	−12%
2019	$83.4B	$79.2B	$90.6B	+4%
2018	$80B	$80B	$111.6B	−14%
2017	$93.6B	$83.8B	$111.1B	−1%
2016	$94.3B	$94.3B	$139.3B	−35%
2015	$145.8B	$143.2B	$176.1B	+3%
2014	$141.5B	$101.6B	$169.3B	+24%
2013	$114.2B	$57.4B	$114.7B	+108%
2012	$54.8B	$32.1B	$57.7B	+78%
2011	$30.7B	$27.9B	$34B	+4%
2010	$29.4B	$27.3B	$44B	−24%
2009	$38.9B	$38.5B	$42.4B	n/a

Companies in Drug Manufacturers - General nearest Gilead Sciences' size, closest first, today.